Drug Discovery

Drug Discovery

EDDC Academic Research Organisation (EARO)

EARO is EDDC's fee-for-service initiative, providing cost-effective access to specialised drug discovery technologies and expertise. Its ISO 9001-certified platforms offer end-to-end services, complemented by tailored consulting support.

RNAi and High-Content Imaging Screening Facility

The RNAi and High-Content Imaging Screening Facility combines functional genomics, automated screening and advanced imaging to help researchers translate biological questions into measurable insights and validated leads.

With expertise in RNAi and CRISPR screening, assay development and automation, high-content imaging, quantitative data analysis and live-cell kinetic analysis, the facility provides end-to-end support from experimental design through screening and biological interpretation, supporting research in oncology, drug discovery and target biology.